Masimo Corp
NASDAQ:MASI
Masimo Corp
NASDAQ:MASI
Price:
136.14 USD
0.67%
Market Closed
Updated:
Apr 28, 2024
P/B
Price to Book Value
Price to Book Value
5.3
Current
6.3
Median
2.2
Industry
Lower
than median
Higher
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=5.3
Market Cap
/
7.2B
Book Value of Equity
1.4B
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| US |
|
Masimo Corp
NASDAQ:MASI
|
7.2B USD | 5.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 9.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 5.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 2.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 3.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 7.8 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 23.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 9.5 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
